×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ORIC – oric pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ORIC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/5
01:00 am
oric
ORIC® Pharmaceuticals Presents Enozertinib Data in NSCLC Patients with HER2 Exon 20 Mutations at the ESMO Asia Congress 2025
Low
Report
ORIC® Pharmaceuticals Presents Enozertinib Data in NSCLC Patients with HER2 Exon 20 Mutations at the ESMO Asia Congress 2025
12/4
09:45 pm
oric
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and Previously Treated NSCLC Patients with EGFR Atypical Mutations at the ESMO Asia Congress 2025
Low
Report
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and Previously Treated NSCLC Patients with EGFR Atypical Mutations at the ESMO Asia Congress 2025
12/3
04:01 pm
oric
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Late-Breaking Oral Presentations in EGFR Atypical and EGFR exon 20 NSCLC at the ESMO Asia Congress 2025
Medium
Report
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Late-Breaking Oral Presentations in EGFR Atypical and EGFR exon 20 NSCLC at the ESMO Asia Congress 2025
12/1
08:52 am
oric
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Poster Presentation in HER2 exon 20 NSCLC at the ESMO Asia Congress 2025 [Yahoo! Finance]
Medium
Report
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Poster Presentation in HER2 exon 20 NSCLC at the ESMO Asia Congress 2025 [Yahoo! Finance]
12/1
08:00 am
oric
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Poster Presentation in HER2 exon 20 NSCLC at the ESMO Asia Congress 2025
Low
Report
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Poster Presentation in HER2 exon 20 NSCLC at the ESMO Asia Congress 2025
11/26
04:34 am
oric
How New ORIC-944 Trial Results and Earnings Update Will Impact ORIC Pharmaceuticals (ORIC) Investors [Yahoo! Finance]
Low
Report
How New ORIC-944 Trial Results and Earnings Update Will Impact ORIC Pharmaceuticals (ORIC) Investors [Yahoo! Finance]
11/24
04:05 pm
oric
ORIC® Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
Low
Report
ORIC® Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference
Date
Time
Symbol
Company Name
Action
%Chg
11/13/2025
04:10 pm
ORIC
oric pharmaceuticals, inc.
BEAT
Report
2.3%
oric pharmaceuticals, inc.
8/12/2025
04:05 pm
ORIC
oric pharmaceuticals, inc.
MISS
Report
3.3%
oric pharmaceuticals, inc.
5/5/2025
04:05 pm
ORIC
oric pharmaceuticals, inc.
BEAT
Report
-11.4%
oric pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/17
08:17 pm
oric
Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: COLUMN GROUP II, LP
Medium
Report
Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: COLUMN GROUP II, LP
11/13
06:15 pm
oric
Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: ALKEON CAPITAL MANAGEMENT LLC
Low
Report
Form SCHEDULE 13G/A Oric Pharmaceuticals, Filed by: ALKEON CAPITAL MANAGEMENT LLC
10/8
05:37 pm
oric
Form 4 Oric Pharmaceuticals, For: Oct 06 Filed by: Piscitelli Dominic
Low
Report
Form 4 Oric Pharmaceuticals, For: Oct 06 Filed by: Piscitelli Dominic
10/8
05:35 pm
oric
Form 4 Oric Pharmaceuticals, For: Oct 06 Filed by: Chacko Jacob
Low
Report
Form 4 Oric Pharmaceuticals, For: Oct 06 Filed by: Chacko Jacob
10/6
04:23 pm
oric
Form 144 Oric Pharmaceuticals, Filed by: Piscitelli Dominic
Medium
Report
Form 144 Oric Pharmaceuticals, Filed by: Piscitelli Dominic
10/3
07:18 pm
oric
Form 4 Oric Pharmaceuticals, For: Oct 03 Filed by: Heyman Richard A.
High
Report
Form 4 Oric Pharmaceuticals, For: Oct 03 Filed by: Heyman Richard A.
10/2
07:19 pm
oric
Form 4 Oric Pharmaceuticals, For: Sep 30 Filed by: Chacko Jacob
Low
Report
Form 4 Oric Pharmaceuticals, For: Sep 30 Filed by: Chacko Jacob
9/24
04:31 pm
oric
Form 4 Oric Pharmaceuticals, For: Sep 22 Filed by: Chacko Jacob
Low
Report
Form 4 Oric Pharmaceuticals, For: Sep 22 Filed by: Chacko Jacob
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: